Patient is unable to communicate and caregiver/informant is unavailable to provide information. Risk

Similar documents
Denominator Exceptions

Screening and Management of Behavioral and Psychiatric Symptoms Associated with Dementia

All visits for patients with diagnosis of epilepsy. Denominator Statement Denominator Exceptions

Measure #154 (NQF: 0101): Falls: Risk Assessment National Quality Strategy Domain: Patient Safety

Pain Assessment and Follow-Up for Patients with Dementia

Quality ID #154 (NQF: 0101): Falls: Risk Assessment National Quality Strategy Domain: Patient Safety

All patients with a diagnosis of treatment resistant (intractable) epilepsy.* Denominator Statement

Oncology Nursing Society Registry in Collaboration with CE City 2015 Performance Measure Specifications

2017 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process

Do Not Cite. Draft for Work Group Review.

Female patients or caregivers counseled* at least once a year about how epilepsy and its treatment may affect contraception OR pregnancy.

Tobacco Use: Screening & Cessation Intervention

Quality ID #293: Parkinson s Disease: Rehabilitative Therapy Options National Quality Strategy Domain: Communication and Care Coordination

Measure #412: Documentation of Signed Opioid Treatment Agreement National Quality Strategy Domain: Effective Clinical Care

MEASURE #9: MIGRAINE OR CERVICOGENIC HEADACHE RELATED DISABILITY FUNCTIONAL STATUS Headache Quality Improvement Only

PQRS in TRAKnet 2015 GUIDE TO SUBMIT TING AND REPORTING PQRS IN 2015 THROUGH TRAKNET

Measure #409: Clinical Outcome Post Endovascular Stroke Treatment National Quality Strategy Domain: Effective Clincial Care

NQF-ENDORSED VOLUNTARY CONSENSUS STANDARDS FOR HOSPITAL CARE. Measure Information Form Collected For: CMS Outcome Measures (Claims Based)

NQF-ENDORSED VOLUNTARY CONSENSUS STANDARD FOR HOSPITAL CARE. Measure Information Form Collected For: CMS Outcome Measures (Claims Based)

Measure #402: Tobacco Use and Help with Quitting Among Adolescents National Quality Strategy Domain: Community / Population Health

MEASURE #4: Overuse of Barbiturate Containing Medications for Primary Headache Disorders Headache

Measure #408: Opioid Therapy Follow-up Evaluation National Quality Strategy Domain: Effective Clinical Care

Quality ID #291: Parkinson s Disease: Cognitive Impairment or Dysfunction Assessment National Quality Strategy Domain: Effective Clinical Care

Status: Draft for Work Group Approval and Public Comment June 23, 2015

Measure #383 (NQF 1879): Adherence to Antipsychotic Medications For Individuals with Schizophrenia National Quality Strategy Domain: Patient Safety

Management of Heart Failure: Review of the Performance Measures by the Performance Measurement Committee of the American College of Physicians

Measure #6: ALS Noninvasive Ventilation Treatment for Respiratory Insufficiency Discussed Amyotrophic Lateral Sclerosis

Balancing Glycemic Overtreatment and Undertreatment for Seniors: An Out of Range (OOR) Population Health Safety Measure

2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY

Translating Health Services Research in Sickle Cell Disease to Policy

Management of Heart Failure: Review of the Performance Measures by the Performance Measurement Committee of the American College of Physicians

Chapter 5: Acute Kidney Injury

Measure #106 (NQF 0103): Adult Major Depressive Disorder (MDD): Comprehensive Depression Evaluation: Diagnosis and Severity

College of American Pathologists (CAP)/ Physician Consortium for Performance Improvement. Pathology Physician Performance Measurement Set

Measure Reporting via Registry: CPT only copyright 2015 American Medical Association. All rights reserved. 11/17/2015 Page 1 of 9

NUMERATOR: All patients with a diagnosis of Parkinson s Disease who were assessed for cognitive impairment or dysfunction in the past 12 months

Measure Components Numerator Statement

Pharmacological Treatment of Dementia

RE: Draft CMS Quality Measure Development Plan: Supporting the Transition to the Merit-based Incentive Payment System and Alternative Payment Models

Understanding Hierarchical Condition Categories (HCC)

Hepatitis C (HCV) Digestive Health Recognition Program

Note: This is an outcome measure and will be calculated solely using registry data.

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process

ISCHEMIC VASCULAR DISEASE (IVD) MEASURES GROUP OVERVIEW

Age 18 years and older BMI 18.5 and < 25 kg/m 2

Hypoglycemia and Quality Measurement

DESCRIPTION: Percentage of patients aged 5 years and older with a diagnosis of persistent asthma who were prescribed long-term control medication

Share the care: Falls Prevention is everyones business

Measure #412: Documentation of Signed Opioid Treatment Agreement National Quality Strategy Domain: Effective Clinical Care

Quality ID #1 (NQF 0059): Diabetes: Hemoglobin A1c (HbA1c) Poor Control (>9%) National Quality Strategy Domain: Effective Clinical Care

DENOMINATOR: Patients undergoing endovascular lower extremity revascularization

COMMUNITY ONCOLOGY ALLIANCE YOU WON T BELIEVE WHAT CMS WILL BE REPORTING ON YOUR ONCOLOGISTS

Measure #117 (NQF 0055): Diabetes: Eye Exam National Quality Strategy Domain: Effective Clinical Care

NATIONAL QUALITY FORUM

Measure #403: Adult Kidney Disease: Referral to Hospice National Quality Strategy Domain: Patient and Caregiver-Centered Experience and Outcomes

2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: CLAIMS, REGISTRY

A. Service Specification

MEASURE #1: MEDICATION PRESCRIBED FOR ACUTE MIGRAINE ATTACK Headache

Measure #355: Unplanned Reoperation within the 30 Day Postoperative Period National Quality Strategy Domain: Patient Safety

2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: CLAIMS, REGISTRY

UpandAbout. Pathways for the prevention and management of falls and fragility fractures. Quick reference guide 2009

NATIONAL QUALITY FORUM

Measure #72 (NQF 0385): Colon Cancer: Chemotherapy for AJCC Stage III Colon Cancer Patients National Quality Strategy Domain: Effective Clinical Care

2018 CMS Web Interface

Age 18 years and older BMI 18.5 and < 25 kg/m 2

NQF-Endorsed Measures for Endocrine Conditions: Cycle 2, 2014

At the completion of this educational activity, the learner will be able to understand:

SCREENING AND PREVENTION

Accuracy of validated falls risk assessment tools and clinical judgement

Quality ID #131 (NQF 0420): Pain Assessment and Follow-Up National Quality Strategy Domain: Communication and Care Coordination

The Cost Burden of Worsening Heart Failure in the Medicare Fee For Service Population: An Actuarial Analysis

Over 425 Members Strong

Ratified by: Care and Clinical Policies Date: 17 th February 2016

HERTS VALLEYS CCG PALLIATIVE AND END OF LIFE CARE STRATEGY FOR ADULTS AND CHILDREN

ACO Congress Conference Pre Session Clinical Performance Measurement

Measure #164 (NQF 0129): Coronary Artery Bypass Graft (CABG): Prolonged Intubation National Quality Strategy Domain: Effective Clinical Care

Comparison of Medicare Fee-for-Service Beneficiaries Treated in Ambulatory Surgical Centers and Hospital Outpatient Departments

Measuring Hypertension Control. Reporting Methods for Measure Up/Pressure Down

Measure #383 (NQF 1879): Adherence to Antipsychotic Medications For Individuals with Schizophrenia National Quality Strategy Domain: Patient Safety

CMS-3311-P 100 TABLE 6: MEANINGFUL USES OBJECTIVES AND MEASURES FOR 2015 THROUGH 2017

2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY

Measure #155 (NQF: 0101): Falls: Plan of Care National Quality Strategy Domain: Communication and Care Coordination

Quality ID #6 (NQF 0067): Coronary Artery Disease (CAD): Antiplatelet Therapy National Quality Strategy Domain: Effective Clinical Care

2017 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Outcome

Quality ID #435: Quality of Life Assessment For Patients With Primary Headache Disorders National Quality Strategy Domain: Effective Clinical Care

Quality Metrics & Immunizations

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Outcome

Measure #110 (NQF 0041): Preventive Care and Screening: Influenza Immunization National Quality Strategy Domain: Community/Population Health

Measure #250 (NQF 1853): Radical Prostatectomy Pathology Reporting National Quality Strategy Domain: Effective Clincial Care

Quality ID #155 (NQF: 0101): Falls: Plan of Care National Quality Strategy Domain: Communication and Care Coordination

Update on Falls Prevention Research

Parkinson s National Audit 2015

2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY

Consensus Core Set: ACO and PCMH / Primary Care Measures Version 1.0

NUMERATOR: Reports that include the pt category, the pn category and the histologic grade

2017 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Outcome

Colorado State Innovation Model (SIM) Clinical Quality Measures (CQMs) Reporting Schedules

Using the NIH Collaboratory's and PCORnet's distributed data networks for clinical trials and observational research - A preview

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process

2018 CMS Web Interface

Transcription:

Falls Outcome for Patients with Parkinson s Disease Measure Description Percentage of patients with PD who experienced a fall in the preceding six months. Note: A lower score is desirable. Measure Components Numerator Patients with PD who experienced one fall in the preceding six months. Statement Denominator All patients with a diagnosis of PD. Statement Denominator Exceptions Patient is unable to communicate and caregiver/informant is unavailable to provide information. Risk See AAN Statement on Comparing Outcomes of Patients in Appendix A. Adjustment Model Supporting Guideline & Other The following clinical recommendation statements are quoted verbatim from the referenced clinical guidelines and represent the evidence base for the measure: References For all people with PD at risk of falling, please refer to NICE guideline 161.(1) Older people who present for medical attention because of a fall, or report recurrent falls in the past year, or demonstrate abnormalities of gait and/or balance should be offered a multifactorial falls risk assessment. This assessment should be performed by a healthcare professional with appropriate skills and experience, normally in the setting of a specialist falls service. This assessment should be part of an individualised, multifactorial intervention.(2) Multifactorial assessment may include the following: - identification of falls history - assessment of gait, balance and mobility, and muscle weakness - assessment of osteoporosis risk - assessment of the older person's perceived functional ability and fear relating to falling - assessment of visual impairment - assessment of cognitive impairment and neurological examination - assessment of urinary incontinence - assessment of home hazards - cardiovascular examination and medication review.(2) All older people with recurrent falls or assessed as being at increased risk of falling should be considered for an individualised multifactorial intervention. In successful multifactorial intervention programmes the following specific components are common (against a background of the general diagnosis and management of causes and recognised risk factors): 33

- strength and balance training - home hazard assessment and intervention - vision assessment and referral - medication review with modification/withdrawal.(2) Following treatment for an injurious fall, older people should be offered a multidisciplinary assessment to identify and address future risk and individualised intervention aimed at promoting independence and improving physical and psychological function.(2) Measure Importance Relationship to The desired outcome is to reduce and eliminate falls. Desired Outcome Opportunity for Improvement Patients with PD are more likely to fall than their health age-matched peers, and falls are often devastating for this population facing higher morbidity and mortality.(3) Following a fall there is risk of increased costs of care, fear of future falls, repeated falls, and reduced health-related quality of life.(4) In a 2013 study by Baek reviewing compliance with quality measure recommendations, it was noted provider compliance rate for assessing fall risk at every visit was 34.6% indicating that providers could do more to assess and treat falls in practice.(5) National Quality Strategy Domains Exception Justification Harmonization with Existing Measures This measure focuses on number of patients who fall, allowing provider variance in how best to identify and treat fall risk in patient populations. The work group recommends that when querying number of falls >0 patients should be referred for physical therapy, encouraged to exercise and consider occupational or physiotherapy assessment for walking aids. Please see the National Parkinson Foundation Task Force for detailed recommendations.(3) Patient and Family Engagement Patient Safety Care Coordination Population/Public Health Efficient Use of Healthcare Resources Clinical Process/Effectiveness Patient or informant must be able to provide information for assessment of number of falls to be valid. This is an outcome measure, which differs from the existing fall risk screening measures: Patients aged 65 years and older who were screened for future fall risk at least once within 12 months. (ACO#13/NQF#0101) 34

Patients aged 65 years and older with a history of falls who had a risk assessment for falls completed within 12 months. (PQRS #154) Measure Designation Measure Purpose Type of Measure Level of Measurement Care Setting Data Source Existing measures (e.g., ACO Measure #13/NQF #0101, PQRS Measure #154) focus on screening individuals aged 65 and older. All patients with PD should be assessed and offered interventions to reduce falls, not just those aged 65 years and older, and as a result this measure was recommended. Quality improvement Accountability Process Outcome Structure Individual Provider Practice System Outpatient Inpatient Skilled Nursing Home Emergency Departments and Urgent Care Electronic health record (EHR) data Administrative Data/Claims Chart Review Registry References 1. NICE National Institute for Health and Care Excellence (NICE). Parkinson s Disease: National Clinical Guideline for Diagnosis and Management in Primary and Secondary Care. NICE Clinical Guidelines 35. National Collaborating Centre for Chronic Conditions (UK). London: Royal College of Physicians; 2006. 2. NICE National Institute for Health and Care Excellence (NICE). Falls: assessment and prevention of falls in older people. NICE clinical guideline 161. June 2013. 315p. 3. van der Marck MA, Klok MP, Okun MS, et al. Consensus-based clinical practice recommendations for the examination and management of falls in patients with Parkinson's disease. Parkinsonism Relat Disord. 2014;20(4):360-369. 4. Fletcher E, Goodwin VA, Richards SH, et al. An exercise intervention to prevent falls in Parkinson's: an economic evaluation. BMC Health Serv Res. 2012 Nov 23;12:426-435. 5. Baek WS, Swenseid SS, Poon KT. Quality Care Assessment of Parkinson s Disease at a Tertiary Medical Center. International Journal of Neuroscience 2013; 123(4): 221-225. Technical Specifications: Electronic Health Record (EHR) Data The AAN is in the process of creating code value sets and the logic required for electronic capture of the quality measures with EHRs. A listing of the quality data model elements, code 35

value sets, and measure logic (through the CMS Measure Authoring Tool) for each of the PD measures will be made available at a later date. Technical Specifications: Administrative Data (Claims) Administrative claims data collection requires users to identify the eligible population (denominator) and numerator using codes recorded on claims or billing forms (electronic or paper). Users report a rate based on all patients in a given practice for whom data are available and who meet the eligible population/ denominator criteria. Denominator (Eligible Population) ICD-9 Code ICD-10 Code 332.0 (Paralysis agitans) G20 Parkinson s Disease Hemiparkinsonism Idiopathic Parkinsonism or Parkinson s Disease Paralysis agitans Parkinsonims or Parkinson s disease NOS Primary Parkinsonism or Parkinson s disease AND CPT E/M Service Code: 99201, 99202, 99203, 99204, 99205 (Office or other outpatient visit-new Patient); 99211, 99212, 99213, 99214, 99215 (Office or other outpatient visit-established Patient); 99241, 99242, 99243, 99244, 99245 (Office or Other Outpatient Consultation-New or Established Patient); 99304, 99305, 99306, 99307, 99308, 99309, 99310 (Nursing Home Consultation); 99221-99223 (Initial Hospital Care); 99231-99233 (Subsequent Hospital Care); 99238-99239 (Hospital Discharge); 99251-99255 (Initial Inpatient Consultation); 99281-99285(Emergency Department); 99201-99205 or 99211-99215 (Urgent Care). 36

Appendix A AAN Statement on Comparing Outcomes of Patients Why this statement: Characteristics of patients can vary across practices and differences in those characteristics may impact the differences in health outcomes among those patients. Some examples of these characteristics are: demographics, co-morbidities, socioeconomic status, and disease severity. Because these variables are typically not under the control of a clinician, it would be inappropriate to compare outcomes of patients managed by different clinicians and practices without accounting for those differences in characteristics among patients. There are many approaches and models to improve comparability, but this statement will focus on risk adjustment. This area continues to evolve (1), and the AAN will revisit this statement regularly to ensure accuracy, as well as address other comparability methods (2) should they become more common. AAN quality measures are used primarily to demonstrate compliance with evidence-based and consensus-based best practices within a given practice as a component of a robust quality improvement program. The AAN includes this statement to caution against using certain measures, particularly outcome measures, for comparison to other individuals/practices/hospitals without the necessary and appropriate risk adjustment. What is Risk Adjustment: Risk adjustment is a statistical approach that can make populations more comparable by controlling for patient characteristics (most commonly adjusted variable is a patient s age) that are associated with outcomes but are beyond the control of the clinician. By doing so, the processes of care delivered and the outcomes of care can be more strongly linked. Comparing measure results from practice to practice: For process measures, the characteristics of the population are generally not a large factor in comparing one practice to another. Outcome measures, however, may be influenced by characteristics of a patient that are beyond the control of a clinician.(3) For example, demographic characteristics, socioeconomic status, or presence of comorbid conditions, and disease severity may impact quality of life measurements. Unfortunately, for a particular outcome, there may not be sufficient scientific literature to specify the variables that should be included in a model of risk adjustment. When efforts to risk adjust are made, for example by adjusting socioeconomic status and disease severity, values may not be documented in the medical record, leading to incomplete risk adjustment. When using outcome measures to compare one practice to another, a methodologist, such as a health researcher, statistician, actuary or health economist, ought to ensure that the populations are comparable, apply the appropriate methodology to account for differences or state that no methodology exists or is needed. Use of measures by other agencies for the purpose of pay-for-performance and public reporting programs: AAN measures, as they are rigorously developed, may be endorsed by the National Quality Forum or incorporated into Centers for Medicare & Medicaid Services (CMS) and private payer programs. 52

It is important when implementing outcomes measures in quality measurement programs that a method be employed to account for differences in patients beyond a clinicians control such as risk adjustment. References and Additional Reading for AAN Statement on Comparing Outcomes of Patients 1. Shahian DM, Wolf RE, Iezzoni LI, Kirle L, Normand SL. Variability in the measurement of hospital-wide mortality rates. N Engl J Med 2010;363(26):2530-2539. Erratum in: N Engl J Med 2011;364(14):1382. 2. Psaty BM, Siscovick DS. Minimizing bias due to confounding by indication in comparative effectiveness research: the importance of restriction. JAMA 2010;304(8):897-898. 3. National Quality Forum. Risk Adjustment for Socioeconomic Status or Other Sociodemographic Factors. August 2014. Available at: http://www.qualityforum.org/publications/2014/08/risk_adjustment_for_socioeconomic_statu s_or_other_sociodemographic_factors.aspx Accessed on January 8, 2015. Sharabiani MT, Aylin P, Bottle A. Systematic review of comorbidity indices for administrative data. Med Care. 2012;50(12):1109-1118. Pope GC, Kauter J, Ingber MJ, et al. for The Centers for Medicare & Medicaid Services Office of Research, Development, and Information. Evaluation of the CMS-HCC Risk Adjustment Model. March 2011. Available at: http://www.cms.gov/medicare/healthplans/medicareadvtgspecratestats/downloads/evaluation_risk_ adj_model_2011.pdf Accessed on January 8, 2015. 53